Cardiology

Understanding the risks of cell therapy for heart repair

A type of cell that plays a crucial role in tissue repair after a heart attack may also inadvertently be why cutting-edge cell therapies cause an increased risk of rhythm disorders, according to a new study from the Universities ...

Cardiology

Results from the MITHRAS trial reported at TCT Connect

The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with ...

page 5 from 5